Cash from Investing (Quarterly) Chart

Historical Cash from Investing (Quarterly) Data

View and export this data back to 1998. Start Trial.
Date Value
June 30, 2026 -13.00M
March 31, 2026 -95.00M
December 31, 2025 -145.00M
September 30, 2025 -58.00M
June 30, 2025 -102.00M
March 31, 2025 -172.00M
December 31, 2024 -58.00M
September 30, 2024 -135.00M
June 30, 2024 -326.00M
March 31, 2024 -166.00M
December 31, 2023 -327.00M
September 30, 2023 -474.00M
June 30, 2023 -306.00M
March 31, 2023 -47.00M
December 31, 2022 -70.00M
September 30, 2022 -166.00M
June 30, 2022 -41.00M
March 31, 2022 -37.00M
December 31, 2021 -208.16M
September 30, 2021 -187.04M
June 30, 2021 -119.00M
March 31, 2021 -223.24M
December 31, 2020 -25.67M
September 30, 2020 -8.849M
June 30, 2020 -15.85M
Date Value
March 31, 2020 -84.19M
December 31, 2019 267.11M
September 30, 2019 -51.86M
June 30, 2019 -38.04M
March 31, 2019 -552.44M
December 31, 2018 -48.00M
September 30, 2018 -71.79M
June 30, 2018 -64.20M
March 31, 2018 -296.60M
December 31, 2017 -28.76M
September 30, 2017 -153.14M
June 30, 2017 -156.80M
March 31, 2017 -38.77M
December 31, 2016 -158.05M
September 30, 2016 -75.08M
June 30, 2016 -52.31M
March 31, 2016 -103.71M
December 31, 2015 -130.10M
September 30, 2015 -105.88M
June 30, 2015 -75.64M
March 31, 2015 -30.52M
December 31, 2014 -83.08M
September 30, 2014 -169.06M
June 30, 2014 -119.00M
March 31, 2014 -250.89M

Cash From Investing Definition

Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.

Read full definition.

Cash from Investing (Quarterly) Range, Past 5 Years

View Cash from Investing (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Investing (Quarterly) Benchmarks

View Cash from Investing (Quarterly) Benchmarks
Start Trial
Cencora, Inc. -240.15M
Accendra Health, Inc. -31.24M
Fuse Medical, Inc. --
Cardinal Health, Inc. -284.00M
McKesson Corp. 1.024B